Sifting through the surfeit of neuroinflammation tracers
暂无分享,去创建一个
M. Breakspear | P. Cumming | R. Banati | N. Vasdev | P. Thomas | Omkar L Patkar | Bjorn Burgher | Guo-Jun Liu | B. Burgher
[1] Jennifer M. Coughlin,et al. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia , 2018, Molecular Psychiatry.
[2] Roger N Gunn,et al. 11C-DPA-713 has much greater specific binding to translocator protein 18 kDa (TSPO) in human brain than 11C-(R)-PK11195 , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] N. Albert,et al. TSPO PET for glioma imaging using the novel ligand 18F-GE-180: first results in patients with glioblastoma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Pontus Plavén-Sigray,et al. Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data , 2017, EJNMMI Research.
[5] C. Svarer,et al. The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test–Retest Study , 2017, The Journal of Nuclear Medicine.
[6] P. Matthews,et al. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] N. Mori,et al. Depiction of microglial activation in aging and dementia: Positron emission tomography with [11C]DPA713 versus [11C](R)PK11195 , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] H. Ohba,et al. Quantification of ONO-2952 Occupancy of 18-kDaTranslocator Protein in Conscious Monkey Brains using Positron Emission Tomography , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[9] R. Narendran,et al. Brain translocator protein occupancy by ONO‐2952 in healthy adults: A Phase 1 PET study using [11C]PBR28 , 2017, Synapse.
[10] Talakad G. Lohith,et al. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain , 2017, The Journal of Nuclear Medicine.
[11] R. Banati,et al. Epigenetic Silencing of the Human 18 kDa Translocator Protein in a T Cell Leukemia Cell Line. , 2017, DNA and cell biology.
[12] M. Ewers,et al. Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis , 2017, Front. Aging Neurosci..
[13] R. Banati,et al. Functional gains in energy and cell metabolism after TSPO gene insertion , 2017, Cell cycle.
[14] I. Buvat,et al. Acute Morphine Exposure Increases the Brain Distribution of [18F]DPA-714, a PET Biomarker of Glial Activation in Nonhuman Primates , 2016, The international journal of neuropsychopharmacology.
[15] A. Meyer-Lindenberg,et al. Microglia Activation and Schizophrenia: Lessons From the Effects of Minocycline on Postnatal Neurogenesis, Neuronal Survival and Synaptic Pruning. , 2016, Schizophrenia bulletin.
[16] I. Buvat,et al. Impact of endothelial TSPO on the quantification of 18 F-DPA-714 , 2017 .
[17] Jennifer M. Coughlin,et al. Imaging of Glial Cell Activation and White Matter Integrity in Brains of Active and Recently Retired National Football League Players , 2017, JAMA neurology.
[18] F. Turkheimer,et al. Pseudo-reference regions for glial imaging with 11 C-PBR28: investigation in two clinical cohorts , 2017 .
[19] M. Fulham,et al. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111 , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[20] Wei He,et al. Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile , 2016, PloS one.
[21] R. Hinz,et al. In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [11C](R)-PK11195 positron emission tomography study , 2016, Molecular Psychiatry.
[22] R. Banati,et al. The impact of high and low dose ionising radiation on the central nervous system , 2016, Redox biology.
[23] D. Sharp,et al. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[24] A. Waldman,et al. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein , 2016, The Journal of Nuclear Medicine.
[25] Response to Narendran and Frankle: The Interpretation of PET Microglial Imaging in Schizophrenia. , 2016, The American journal of psychiatry.
[26] R. Narendran,et al. Comment on Analyses and Conclusions of "Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study". , 2016, The American journal of psychiatry.
[27] Simon Cervenka,et al. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects , 2016, Brain, Behavior, and Immunity.
[28] Jennifer M. Coughlin,et al. In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma , 2016, Translational Psychiatry.
[29] Adriaan A Lammertsma,et al. Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography. , 2016, Biochimica et biophysica acta.
[30] D. Stocco,et al. Translocator Protein (TSPO) Affects Mitochondrial Fatty Acid Oxidation in Steroidogenic Cells. , 2016, Endocrinology.
[31] Kanako Morohaku,et al. Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis* , 2015, The Journal of Biological Chemistry.
[32] P. Cumming,et al. Specific binding of [18F]fluoroethyl‐harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain , 2015, Journal of neurochemistry.
[33] Yiyun Huang,et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET , 2015, Proceedings of the National Academy of Sciences.
[34] R. Boisgard,et al. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images. , 2015, Journal of medicinal chemistry.
[35] Kimberly J. Jenko,et al. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein. , 2015, JAMA neurology.
[36] Y. Fontyn,et al. Differential influence of propofol and isoflurane anesthesia in a non‐human primate on the brain kinetics and binding of [18F]DPA‐714, a positron emission tomography imaging marker of glial activation , 2015, European Journal of Neuroscience.
[37] P. Remy,et al. Optimized Quantification of Translocator Protein Radioligand 18F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers , 2015, The Journal of Nuclear Medicine.
[38] D. Brooks,et al. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort? , 2015, The Journal of Nuclear Medicine.
[39] O. Garaschuk,et al. Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.
[40] Jean-Dominique Gallezot,et al. Comparison of standardized uptake values with volume of distribution for quantitation of [(11)C]PBR28 brain uptake. , 2015, Nuclear medicine and biology.
[41] Alan A. Wilson,et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. , 2015, JAMA psychiatry.
[42] R. Boellaard,et al. Quantification of [18F]DPA-714 binding in the human brain: initial studies in healthy controls and Alzheimer's disease patients , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[43] G. Searle,et al. The Simplified Reference Tissue Model: Model Assumption Violations and Their Impact on Binding Potential , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[44] R. Garavito,et al. Crystal structures of translocator protein (TSPO) and mutant mimic of a human polymorphism , 2015, Science.
[45] Wayne A Hendrickson,et al. Structure and activity of tryptophan-rich TSPO proteins , 2015, Science.
[46] C. Halldin,et al. Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[47] E. Rabiner,et al. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[48] C. Svarer,et al. In Vivo Quantification of Cerebral Translocator Protein Binding in Humans Using 6-Chloro-2-(4′-123I-Iodophenyl)-3-(N,N-Diethyl)-Imidazo[1,2-a]Pyridine-3-Acetamide SPECT , 2014, The Journal of Nuclear Medicine.
[49] David Zahra,et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout , 2014, Nature Communications.
[50] A. McAllister,et al. Alterations in Immune Cells and Mediators in the Brain: It's Not Always Neuroinflammation! , 2014, Brain pathology.
[51] Adam J. Svahn,et al. Emergent Properties of Microglia , 2014, Brain pathology.
[52] M. Graeber. Neuroinflammation: No Rose by Any Other Name , 2014, Brain pathology.
[53] Richard B. Banati,et al. The 18 kDa Translocator Protein, Microglia and Neuroinflammation , 2014, Brain pathology.
[54] Kimberly J. Jenko,et al. Synthesis and Evaluation of Translocator 18 kDa Protein (TSPO) Positron Emission Tomography (PET) Radioligands with Low Binding Sensitivity to Human Single Nucleotide Polymorphism rs6971 , 2014, ACS chemical neuroscience.
[55] D. Stocco,et al. Peripheral Benzodiazepine Receptor/Translocator Protein Global Knock-out Mice Are Viable with No Effects on Steroid Hormone Biosynthesis*♦ , 2014, The Journal of Biological Chemistry.
[56] A. Arefin,et al. ‘Neuroinflammation’ differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared , 2014, neurogenetics.
[57] P. Cumming,et al. Radiosynthesis and Validation of 18F-FP-CMT, a Phenyltropane with Superior Properties for Imaging the Dopamine Transporter in Living Brain , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[58] F. Ricchelli,et al. Regulation of the Mitochondrial Permeability Transition Pore by the Outer Membrane Does Not Involve the Peripheral Benzodiazepine Receptor (Translocator Protein of 18 kDa (TSPO))* , 2014, The Journal of Biological Chemistry.
[59] Alessandra Bertoldo,et al. Kinetic Modeling without Accounting for the Vascular Component Impairs the Quantification of [11C]PBR28 Brain PET Data , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[60] S. Becker,et al. Structure of the Mitochondrial Translocator Protein in Complex with a Diagnostic Ligand , 2014, Science.
[61] Paul M. Matthews,et al. Eratum: Determination of [ 11 C]PBR28 binding potential in vivo: A first human TSPO blocking study (Journal of Cerebral Blood Flow and Metabolism (2014) 34 (1256)) , 2014 .
[62] W. R. Butler,et al. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. , 2014, Endocrinology.
[63] Roger N Gunn,et al. Quantification of the Specific Translocator Protein Signal of 18F-PBR111 in Healthy Humans: A Genetic Polymorphism Effect on In Vivo Binding , 2013, The Journal of Nuclear Medicine.
[64] R. Carson,et al. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: A [11C]PBR28 PET study , 2013, Brain, Behavior, and Immunity.
[65] B. Gulyás,et al. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[66] Kimberly J. Jenko,et al. A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[67] Annelaure Damont,et al. Metabolism and Quantification of [18F]DPA-714, a New TSPO Positron Emission Tomography Radioligand , 2013, Drug Metabolism and Disposition.
[68] Philippe Hantraye,et al. Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.
[69] G. Bormans,et al. Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[70] Alan A. Wilson,et al. Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[71] Ronald Boellaard,et al. Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[72] V. Papadopoulos,et al. Structural and functional evolution of the translocator protein (18 kDa). , 2012, Current molecular medicine.
[73] M. Gavish,et al. The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS). , 2012, Current molecular medicine.
[74] M. Gavish,et al. The role of 18 kDa mitochondrial translocator protein (TSPO) in programmed cell death, and effects of steroids on TSPO expression. , 2012, Current molecular medicine.
[75] Christer Halldin,et al. Kinetic analysis and test-retest variability of the radioligand [11C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects , 2012, EJNMMI Research.
[76] M. Thaning,et al. [¹⁸F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO). , 2012, Bioorganic & medicinal chemistry letters.
[77] Roger N Gunn,et al. An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[78] D. Flockerzi,et al. Modeling the light- and redox-dependent interaction of PpsR/AppA in Rhodobacter sphaeroides. , 2011, Biophysical journal.
[79] Sylvain Houle,et al. Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[80] M. Grégoire,et al. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[81] M. Berk,et al. eview athways underlying neuroprogression in bipolar disorder : Focus on nflammation , oxidative stress and neurotrophic factors , 2010 .
[82] Robert B. Innis,et al. Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.
[83] T. Guilarte,et al. Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS , 2005, Journal of NeuroVirology.
[84] M. Fulham,et al. A rapid solid-phase extraction method for measurement of non-metabolised peripheral benzodiazepine receptor ligands, [(18)F]PBR102 and [(18)F]PBR111, in rat and primate plasma. , 2011, Nuclear medicine and biology.
[85] Koen Van Laere,et al. Preclinical Evaluation of 18F-JNJ41510417 as a Radioligand for PET Imaging of Phosphodiesterase-10A in the Brain , 2010, The Journal of Nuclear Medicine.
[86] Roger N Gunn,et al. Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[87] A. Reynolds,et al. The development of PET radioligands for imaging the translocator protein (18 kDa): What have we learned? , 2010 .
[88] Masahiro Fujita,et al. Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.
[89] M. Gavish,et al. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines , 2010, Apoptosis.
[90] M. Pomper,et al. Initial Evaluation of 11C-DPA-713, a Novel TSPO PET Ligand, in Humans , 2009, Journal of Nuclear Medicine.
[91] Yota Fujimura,et al. Quantification of Translocator Protein (18 kDa) in the Human Brain with PET and a Novel Radioligand, 18F-PBR06 , 2009, Journal of Nuclear Medicine.
[92] J. Goverman. Autoimmune T cell responses in the central nervous system , 2009, Nature Reviews Immunology.
[93] I. Hickie,et al. Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders , 2009, The Medical journal of Australia.
[94] C. Wiley,et al. The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders , 2008, Journal of neuropathology and experimental neurology.
[95] Sylvain Houle,et al. Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.
[96] Ming-Kai Chen,et al. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.
[97] Robert B. Innis,et al. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation , 2008, NeuroImage.
[98] K. Mardon,et al. Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS) , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[99] Jeih-San Liow,et al. Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation , 2007, Journal of Nuclear Medicine.
[100] Tetsuya Suhara,et al. A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation , 2007, Journal of neurochemistry.
[101] Masahiro Fujita,et al. Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain , 2007, Synapse.
[102] Lars H. Pinborg,et al. [123I]Epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: Implications for the use of cerebellum as a reference region , 2007, NeuroImage.
[103] Marie-Claude Asselin,et al. Quantification of PET Studies with the Very High-Affinity Dopamine D2/D3 Receptor Ligand [11C]FLB 457: Re-Evaluation of the Validity of using a Cerebellar Reference Region , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[104] Ryuji Nakao,et al. Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[105] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[106] D. Nutt,et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. , 2006, Trends in pharmacological sciences.
[107] Paul Cumming,et al. Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain , 2006, The European journal of neuroscience.
[108] Paul Cumming,et al. Distribution of PK11195 binding sites in porcine brain studied by autoradiography in vitro and by positron emission tomography , 2006, Synapse.
[109] Paul Cumming,et al. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with manifest hepatic encephalopathy , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[110] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[111] Alexander Gerhard,et al. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study , 2005, NeuroImage.
[112] Yuji Nagai,et al. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.
[113] V. Papadopoulos,et al. A novel Arabidopsis thaliana protein is a functional peripheral-type benzodiazepine receptor. , 2004, Plant & cell physiology.
[114] E. Hamel,et al. Assessment of the peripheral benzodiazepine receptors in human gliomas by two methods , 1998, Journal of Neuro-Oncology.
[115] R B Banati,et al. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.
[116] A. Gee,et al. The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. , 2003, Nuclear medicine and biology.
[117] T. Suhara,et al. [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). , 2003, Bioorganic & medicinal chemistry letters.
[118] R. Banati. Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? , 2002, Journal of Physiology-Paris.
[119] R. Myers,et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury , 2001, Neuroreport.
[120] R B Banati,et al. In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.
[121] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[122] A. Gjedde,et al. Normalization of markers for dopamine innervation in striatum of MPTP‐lesioned miniature pigs with intrastriatal grafts , 2001, Acta neurologica Scandinavica.
[123] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[124] R B Banati,et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.
[125] R. Brown,et al. Location-dependent role of the human glioma cell peripheral-type benzodiazepine receptor in proliferation and steroid biosynthesis. , 2000, Cancer letters.
[126] T. Guilarte,et al. Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.
[127] G. Slegers,et al. High-performance liquid chromatographic determination of [11C]1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline carboxamide in mouse plasma and tissue and in human plasma. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[128] F E Turkheimer,et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis , 1999, Neurology.
[129] Abraham Weizman,et al. Enigma of the peripheral benzodiazepine receptor. , 1999, Pharmacological reviews.
[130] S. Chaki,et al. Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors. , 1999, European journal of pharmacology.
[131] V. Papadopoulos,et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. , 1999, Cancer research.
[132] V. Papadopoulos,et al. Printed in U.S.A. Copyright © 1998 by The Endocrine Society Peripheral-Type Benzodiazepine Receptor Function in Cholesterol Transport. Identification of a Putative Cholesterol Recognition/Interaction Amino Acid Sequence and Consensus Pattern* , 2022 .
[133] M. Snyder,et al. Evidence for a diazepam-binding inhibitor (DBI) benzodiazepine receptor-like mechanism in ecdysteroidogenesis by the insect prothoracic gland , 1998, Cell and Tissue Research.
[134] G. Kroemer,et al. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. , 1998, Experimental cell research.
[135] A. A. Yeliseev,et al. A mammalian mitochondrial drug receptor functions as a bacterial "oxygen" sensor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[136] R B Banati,et al. PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.
[137] V. Papadopoulos,et al. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis , 1997, Steroids.
[138] D. Williams,et al. Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. , 1996, Biochemical pharmacology.
[139] H. Alho,et al. Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[140] Peter Herscovitch,et al. Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to [18F]Cyclofoxy and Positron Emission Tomography , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[141] P. Casellas,et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. , 1993, Life sciences.
[142] J. Regan,et al. Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. , 1991, The Journal of biological chemistry.
[143] V. Papadopoulos,et al. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. , 1990, The Journal of biological chemistry.
[144] H. Vinters,et al. Specific high‐affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and man , 1990, Cancer.
[145] M. Santi,et al. Molecular cloning and expression of cDNA encoding a peripheral-type benzodiazepine receptor. , 1989, The Journal of biological chemistry.
[146] E. Costa,et al. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[147] G. L. Watkins,et al. PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site , 1989, Annals of neurology.
[148] T. F. Murray,et al. Differential Binding Properties of the Peripheral‐Type Benzodiazepine Ligands [3H]PK 11195 and [3H]Ro 5‐4864 in Trout and Mouse Brain Membranes , 1989, Journal of neurochemistry.
[149] T D Lee,et al. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[150] J. Hirsch,et al. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. , 1989, Molecular pharmacology.
[151] A. Guidotti,et al. Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. , 1988, Molecular pharmacology.
[152] P. Skolnick,et al. Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex , 1987, Brain Research Bulletin.
[153] J. Morgan,et al. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[154] G. Le Fur,et al. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. , 1983, Life sciences.
[155] H. Schoemaker,et al. Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex. , 1981, European journal of pharmacology.
[156] C. Braestrup,et al. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. , 1977, Proceedings of the National Academy of Sciences of the United States of America.